myTomorrows raises €10.0M Series B round

9 January 2017· Amsterdam, The Netherlands· health, digital_health, ai, pure_software, b2b, clinical_trials_access

The funding will be used to further accelerate investments in technologies and talent to unburden regulators, physicians, and drug developers from the complex processes of providing access to investigational drugs for patients facing unmet medical needs.

Investors

LeadEQT Ventures

Also participating

Octopus VenturesBalderton CapitalSofinnova Partners

About myTomorrows

Key People

Michel van HartenCEO

Marshall van BeurdenCTO

Vanessa LemariéChief Operating Officer

Ronald BrusFounder

Stage

Series C

Headquarters

Amsterdam, The Netherlands

Founded

2012

Team Size

51–200

Sectors

healthdigital_healthaipure_softwareb2bclinical_trials_access

https://mytomorrows.com/en/

Source: https://eu-startups.com/2017/01/amsterdam-based-mytomorrows-raises-e10-million-to-improve-access-to-drugs-in-development-for-physicians-and-patients/, https://www.octopusgroup.com/ventures/news-insights/2017/drug-access-platform-mytomorrows-raises-10-million/, https://tracxn.com/d/companies/mytomorrows/__z5J1B1nSg4N/funding-and-investors